Yoshitsugu Horio
Nagoya, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 74 publications
Perioperative Durvalumab for Resectable Non-Small Cell Lung Cancer: Updated Outcomes From the Phase III AEGEAN Trial.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: August 28, 2026
Detecting Rare ALK Gene Fusions in Unclassified Spindle Cell Lung Tumors Using Anchored Multiplex PCR/Targeted RNA Next-Generation Sequencing.
Journal: Genes, chromosomes & cancer
Published: April 30, 2026
Five-year prognostic impact of pre-existing interstitial lung disease in non-small cell lung cancer patients treated with anti-PD-1 monotherapy: a retrospective analysis.
Journal: BMC cancer
Published: February 01, 2026
Comprehensive RNA Sequencing Analysis Reveals Heterogeneous Expression of Epstein-Barr Virus Genes in Gastric Cancer.
Journal: Genes, chromosomes & cancer
Published: November 28, 2025
RNA-seq analysis of nintedanib effects on interstitial pneumonia in preoperative NSCLC patients.
Journal: Respiratory medicine
Published: October 10, 2025
Salvage Surgery Following Systemic Therapy in Initially Unresectable Non-Small Cell Lung Cancer.
Journal: Thoracic cancer
Published: October 07, 2025
Identification of novel gene fusions in high-grade serous ovarian carcinoma: implications for tumorigenesis and targeted therapy.
Journal: Cancer genetics
Published: August 12, 2025
Aerogenous Dissemination of DEK::AFF2 Carcinoma : A Prototype of a Previously Underrecognized Pattern of Endobronchial Metastasis From Extrathoracic Malignancies.
Journal: The American journal of surgical pathology
Published: August 11, 2025
Durvalumab Post Concurrent Chemoradiotherapy in Japanese Patients With Limited-Stage Small-Cell Lung Cancer in the Phase 3 ADRIATIC Trial.
Journal: Cancer science
Published: June 05, 2025
Utility of ctDNA-molecular residual disease in predicting minimal residual disease in non-small cell lung cancer patients after radical resection.
Journal: Translational lung cancer research
Published: April 21, 2025
Long-term efficacy and improved overall survival of lorlatinib in anaplastic lymphoma kinase-rearranged lung cancer: is cure a dream or a reality?
Journal: Translational lung cancer research
Published: April 14, 2025
Last Updated: 09/26/2026